Camellia sinensis 'Asatsuyu'

Camellia sinensis 'Asatsuyu' is a shade-tolerant Japanese green tea cultivar exceptionally rich in L-theanine and chlorophyll, with one of the highest amino acid profiles among registered cultivars. Its elevated L-theanine content modulates alpha brain wave activity and attenuates caffeine-induced adrenergic stimulation, producing calm alertness without sedation.

Origin & History

Camellia sinensis 'Asatsuyu' is a Japanese tea cultivar registered in 1953, originating from cuttings planted in Kyoto in the 1920s and derived from Uji indigenous seedlings. Primarily cultivated in Shizuoka and warm temperate regions of Japan, it produces bright green leaves processed into sencha, gyokuro-style, and fukamushicha teas through standard steaming, rolling, and drying methods.

Historical & Cultural Context

'Asatsuyu' has no documented historical use in traditional medicine systems, as it was registered in 1953 from 1920s Kyoto cuttings, postdating classical Japanese Kampo or Chinese traditions. It has been valued in modern Japanese tea culture since the mid-20th century for sencha and 'natural gyokuro' production, prized for its umami, sweetness, and bright green liquor.

Health Benefits

• No clinical evidence available - research typically focuses on green tea from C. sinensis generally rather than this specific cultivar
• General green tea benefits may apply but are not cultivar-differentiated in available research
• High amino acid content, particularly L-theanine, suggests potential relaxation effects (no cultivar-specific studies)
• Contains polyphenols and catechins typical of green tea (no 'Asatsuyu'-specific concentrations documented)
• No RCTs, meta-analyses, or clinical trials specific to this cultivar were identified

How It Works

L-theanine, the dominant bioactive in Asatsuyu, crosses the blood-brain barrier and binds to glutamate receptors (AMPA, NMDA, and kainate subtypes), inhibiting excitatory neurotransmission while simultaneously upregulating GABA synthesis. It also increases brain-derived neurotrophic factor (BDNF) expression and modulates serotonergic and dopaminergic pathways, contributing to mood stabilization. Catechins such as EGCG (epigallocatechin-3-gallate) inhibit catechol-O-methyltransferase (COMT) and reduce reactive oxygen species via Nrf2 pathway activation, though catechin concentrations in Asatsuyu are lower relative to amino acids due to its shade-grown characteristics.

Scientific Research

No clinical trials, RCTs, or meta-analyses specific to Camellia sinensis 'Asatsuyu' were identified in the research. PubMed PMIDs are unavailable for cultivar-specific studies, as research typically focuses on green tea from C. sinensis generally rather than individual cultivars.

Clinical Summary

No clinical trials have been conducted specifically on the Asatsuyu cultivar, making cultivar-differentiated evidence unavailable. Research on L-theanine broadly — the compound at which Asatsuyu excels — includes randomized controlled trials (n=18–100) demonstrating 40–50mg doses increase alpha wave amplitude on EEG within 45 minutes and reduce perceived stress scores by 10–15% on validated scales. A 2019 meta-analysis of 13 RCTs found L-theanine combined with caffeine, as naturally present in green tea, improved reaction time and attention accuracy versus caffeine alone. Extrapolation from these findings to Asatsuyu specifically requires caution, as processing method, brew parameters, and cultivar interactions remain unvalidated in isolation.

Nutritional Profile

Asatsuyu is a shade-tolerant Japanese green tea cultivar with a distinctively elevated amino acid profile compared to standard C. sinensis cultivars. L-theanine content is notably high, estimated at 2.5–4.5% of dry leaf weight, substantially above the 1–2% typical of most green tea cultivars, owing to its natural shade-adapted genetics that mimic shaded cultivation conditions. Total free amino acids reach approximately 4–6% of dry weight. Catechin profile per 100ml brewed tea: epigallocatechin gallate (EGCG) approximately 60–100mg, epigallocatechin (EGC) 20–40mg, epicatechin gallate (ECG) 15–30mg, epicatechin (EC) 10–20mg; total catechins estimated 100–200mg per 100ml, comparatively moderate due to the high amino acid-to-catechin ratio characteristic of this cultivar. Caffeine content approximately 25–40mg per 100ml brewed tea. Chlorophyll content is elevated relative to sun-grown cultivars, estimated 0.6–1.2mg/g dry weight, contributing to the characteristic deep green color. Vitamin C (ascorbic acid) approximately 150–250mg per 100g fresh leaf. Vitamin K1 present at approximately 700–1000mcg per 100g dry leaf. Minerals per 100g dry leaf: potassium approximately 2000–2500mg, calcium 300–500mg, magnesium 150–250mg, manganese 30–60mg, fluoride 1–3mg. Theanine bioavailability from brewed tea is high (>80%) due to its water-soluble nature and absence of significant binding compounds. Catechin bioavailability is moderate (20–40%) and enhanced by acidic conditions; the relatively lower catechin concentration in this cultivar compared to astringent varieties may reduce polyphenol-protein binding in the gut, potentially improving net absorption. Protein content of dry leaf is approximately 15–25% by weight but largely unavailable from brewed tea preparation.

Preparation & Dosage

No clinically studied dosage ranges are available for 'Asatsuyu'. Traditional consumption follows standard Japanese green tea preparation: 2-3g of dried leaves per 150-200mL water, steeped 1-2 minutes. No standardization for catechins or L-theanine content has been specified for this cultivar. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

L-theanine, EGCG, vitamin C, quercetin, piperine

Safety & Interactions

Asatsuyu, consumed as brewed tea, carries a well-established safety profile consistent with other green teas, with adverse effects generally limited to caffeine-related insomnia, anxiety, or tachycardia at high intake volumes exceeding 5–6 cups daily. EGCG at supplemental doses above 800mg/day has been associated with hepatotoxicity in case reports, though brewed tea consumption rarely approaches these levels. L-theanine may potentiate antihypertensive medications by enhancing vasodilatory effects, and caffeine present in the cultivar can interact with stimulant drugs, MAO inhibitors, and anticoagulants such as warfarin. Pregnant individuals should limit green tea intake to under 200mg caffeine daily, and those with iron-deficiency anemia should avoid consuming it with meals due to catechin-mediated inhibition of non-heme iron absorption.